/PRNewswire/ The global lung cancer therapeutics market size is estimated to grow by USD 10.52 billion from 2024-2028, according to Technavio. The market is.
Shanghai- and San Diego-based Degron Therapeutics Inc. secured a potential $1.2 billion deal with Tokyo-headquartered Takeda Pharmaceutical Co. Ltd. May 23 for a multitarget collaboration and exclusive licensing agreement for molecular glue degraders.
/PRNewswire/ The global travel vaccines market size is estimated to grow by USD 3.97 bn from 2024-2028, according to Technavio. The market is estimated to.
Denmark Pharmaceutical Market size is set to grow by USD 852.1 mn from 2024-2028, high investment in pharmaceutical industry to boost the market growth, Technavio prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.